IC Class medications in patients with atrial fibrillation, arterial hypertension, chronic heart failure and intact systolic function

被引：0

作者：

Miller, O. N. ^{[1
]}

Skurikhina, O. N. ^{[1
]}

Starichkov, S. A. ^{[1
]}

机构：

[1] Novosibirsk State Med Univ, Novosibirsk, Russia

来源：

RUSSIAN JOURNAL OF CARDIOLOGY | 2008年 / 04期

关键词：

Atrial fibrillation; arterial hypertension; chronic heart failure; propanorm;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The study assessed clinical effectiveness and safety of propanorm in patients with arterial hypertension, chronic heart failure (CHF) without left ventricular systolic dysfunction, complicated with recurrent paroxysmal or persistent atrial AA fibrillation (AF). It was demonstrated that propanorm was effective and safe and could be combined with beta-adrenoblockers. In 29,3% of the participants, tachyarrhythmia terminated; in another 70,7% AF episode frequency reduced by 75,5%, and total time of AF episodes decreased by 81, 1%.

引用

页码：25 / 33

页数：9

共 50 条

[21] Interstitial Edema of the Interatrial Septum in Patients with Atrial Fibrillation and Chronic Heart Failure
Garganeeva, A. A.
Kirillova, V. V.
Mochula, O. V.
Kuzheleva, E. A.
Batalov, R. E.
Sokolova, L. A.
Popov, S. V.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2023, 174 (06) : 711 - 715
[22] Interstitial Edema of the Interatrial Septum in Patients with Atrial Fibrillation and Chronic Heart Failure
A. A. Garganeeva
V. V. Kirillova
O. V. Mochula
E. A. Kuzheleva
R. E. Batalov
L. A. Sokolova
S. V. Popov
Bulletin of Experimental Biology and Medicine, 2023, 174 : 711 - 715
[23] Clinical characteristics and prognostic impact of atrial fibrillation in patients with chronic heart failure
Gigli, Lorenzo
Ameri, Pietro
Secco, Gianmarco
De Blasi, Gabriele
Miceli, Roberta
Lorenzoni, Alessandra
Torre, Francesco
Chiarella, Francesco
Brunelli, Claudio
Canepa, Marco
WORLD JOURNAL OF CARDIOLOGY, 2016, 8 (11): : 647 - 656
[24] Atrial fibrillation ablation in heart failure patients: improved systolic function after cryoballoon pulmonary vein isolation
Pott, Alexander
Jaeck, Saskia
Schweizer, Christiane
Baumhardt, Michael
Stephan, Tilman
Rattka, Manuel
Weinmann, Karolina
Bothner, Carlo
Scharnbeck, Dominik
Kessler, Mirjam
Rottbauer, Wolfgang
Dahme, Tillman
ESC HEART FAILURE, 2020, 7 (05): : 2258 - 2267
[25] Recurrent atrial fibrillation predictors in patients with arterial hypertension: circadian heart rate variability analysis
Dedov, D. V.
Ivanov, A. P.
Elgardt, I. A.
CARDIOVASCULAR THERAPY AND PREVENTION, 2011, 10 (07): : 45 - 48
[26] Features of Atrial Fibrillation in Patients with Arterial Hypertension and Extracardial Disorders
Khidirova, Lyudmila D.
Yakhontov, David A.
Zenin, Sergei A.
Mamedov, Mehman N.
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2019, 15 (03) : 368 - 373
[27] Natriuretic peptides and chronic heart failure in arterial hypertension patients
Vasuyk, Yu. A.
Khadzegova, A. B.
Ivanova, S. V.
Amirbegishvili, I. M.
Gerasimova, N. I.
Yushchuk, E. N.
Krikunova, O. V.
Bitsuev, V. G.
CARDIOVASCULAR THERAPY AND PREVENTION, 2007, 6 (02): : 75 - 79
[28] Catheter Ablation for Atrial Fibrillation in Systolic Heart Failure Patients: Stone by Stone, a CASTLE
Vrachatis, Dimitrios
Deftereos, Spyridon
Kekeris, Vasileios
Tsoukala, Styliani
Giannopoulos, Georgios
ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW, 2018, 7 (04) : 265 - 272
[29] Plasma inflammatory marker levels in the systolic heart failure patients with and without atrial fibrillation
Tatli, Ersan
Cakar, Mehmet Akif
Yilmaztepe, Mustafa
Barutcu, Ahmet
HEALTHMED, 2012, 6 (11): : 3616 - 3620
[30] Heart remodeling in elderly patients with isolated systolic arterial hypertension and chronic heart failure with preserved left ventricular ejection fraction
Sheiko, S. O.
Kolb, N. O.
ZAPOROZHYE MEDICAL JOURNAL, 2021, 23 (03) : 331 - 337

← 1 2 3 4 5 →